In Levaquin Patent Battle, Daiichi Scores Again
In its second big win in a high-stakes patent battle over the anti-infective drug Levaquin, Japanese drug maker Daiichi Pharmaceutical Co. has been granted summary judgment on its motion for no...To view the full article, register now.
Already a subscriber? Click here to view full article